Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Xiao

Showing results (1091-1100 of 1,147) with videos related to

Pageof 115
Sort By:
Circulation Research|July 31, 2024
AMPK Attenuation of β-Adrenergic Receptor-Induced Cardiac Injury via Phosphorylation of β-Arrestin-1-ser330Mingming Zhao, Ning Cao, Huijun Gu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.
Science (New York, N.Y.)|April 10, 2025
Targeted MYC2 stabilization confers citrus Huanglongbing resistancePingzhi Zhao, Huan Yang, Yanwei Sun, et al.
Stem Cell Research & Therapy|June 14, 2026
Gli1⁺ cell aggregates promote type H vessel formation and orchestrate bone defect regenerationChao Ma, Yu-Ru Gao, Hao Wang, et al.
ACS Applied Materials & Interfaces|January 2, 2024
Nickel Nanoparticles Protruding from Molybdenum Carbide Micropillars with Carbon Layer-Protected Biphasic 0D/1D Heterostructures for Efficient Water SplittingJingqiang Wang, Yu Su, Yan-Jiang Li, et al.
JCO Clinical Cancer Informatics|March 28, 2020
Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic TreatmentBobby Daly, Dmitriy Gorenshteyn, Kevin J Nicholas, et al.
Neurology|April 2, 2025
Incidence Trends and Risk of Recurrent Stroke of Cervical Artery Dissections in the United States Between 2005 and 2019Liqi Shu, Lukas Strelecky, Adam de Havenon, et al.
Cancer|September 25, 2020
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trialDarren R Feldman, Yasser Ged, Chung-Han Lee, et al.
Frontiers in Cardiovascular Medicine|August 9, 2021
Impact of COVID-19 Pandemic on Mechanical Reperfusion in ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Multicenter Retrospective Study From a Non-epicenter RegionQi Mao, Jianhua Zhao, Youmei Li, et al.
The Journal of Clinical Endocrinology and Metabolism|September 4, 2020
Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, ChinaJianfeng Wu, Jianqiang Huang, Guochao Zhu, et al.
Pageof 115

Showing results (1091-1100 of 1,147) with videos related to

Sort By:
Pageof 115
Circulation Research|July 31, 2024
AMPK Attenuation of β-Adrenergic Receptor-Induced Cardiac Injury via Phosphorylation of β-Arrestin-1-ser330Mingming Zhao, Ning Cao, Huijun Gu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.
Science (New York, N.Y.)|April 10, 2025
Targeted MYC2 stabilization confers citrus Huanglongbing resistancePingzhi Zhao, Huan Yang, Yanwei Sun, et al.
Stem Cell Research & Therapy|June 14, 2026
Gli1⁺ cell aggregates promote type H vessel formation and orchestrate bone defect regenerationChao Ma, Yu-Ru Gao, Hao Wang, et al.
ACS Applied Materials & Interfaces|January 2, 2024
Nickel Nanoparticles Protruding from Molybdenum Carbide Micropillars with Carbon Layer-Protected Biphasic 0D/1D Heterostructures for Efficient Water SplittingJingqiang Wang, Yu Su, Yan-Jiang Li, et al.
JCO Clinical Cancer Informatics|March 28, 2020
Building a Clinically Relevant Risk Model: Predicting Risk of a Potentially Preventable Acute Care Visit for Patients Starting Antineoplastic TreatmentBobby Daly, Dmitriy Gorenshteyn, Kevin J Nicholas, et al.
Neurology|April 2, 2025
Incidence Trends and Risk of Recurrent Stroke of Cervical Artery Dissections in the United States Between 2005 and 2019Liqi Shu, Lukas Strelecky, Adam de Havenon, et al.
Cancer|September 25, 2020
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trialDarren R Feldman, Yasser Ged, Chung-Han Lee, et al.
Frontiers in Cardiovascular Medicine|August 9, 2021
Impact of COVID-19 Pandemic on Mechanical Reperfusion in ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Multicenter Retrospective Study From a Non-epicenter RegionQi Mao, Jianhua Zhao, Youmei Li, et al.
The Journal of Clinical Endocrinology and Metabolism|September 4, 2020
Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, ChinaJianfeng Wu, Jianqiang Huang, Guochao Zhu, et al.
Pageof 115